Trim24. By knocking out these genes, the engineered CHO cells exhibited increased resistance to the 43 prototype RNA viruses tested. Thus, omics-guided engineering of mammalian cell culture can be 44 deployed to increase safety in biotherapeutic protein production among many other biomedical 45 applications. 46 47 48
Introduction

51
Chinese hamster ovary (CHO) cells are extensively used to produce biopharmaceuticals 1 for numerous 52 reasons. Though one advantage is their reduced susceptibility to many human virus families 2-4 , there 53 have been episodes of animal viral contamination of biopharmaceutical production runs, mostly from 54 trace levels of viruses in raw materials. These infections have led to expensive decontamination efforts 55 and threatened the supply of critical drugs [5] [6] [7] . Viruses that have halted production of valuable therapeutics 56
include RNA viruses such as Cache Valley virus 6 , Epizootic hemorrhagic disease virus 8 , Reovirus 6 and 57 Vesivirus 2117 9 . Thus, there is a critical need to understand the mechanisms by which CHO cells are 58 infected and how the cells can be universally engineered to enhance their viral resistance 10 . For example, 59
a strategy was proposed to inhibit infection of CHO cells by minute virus of mice by engineering 60 glycosylation 11 . We present an alternative strategy to prevent infections of a number of RNA viruses 61 with different genomic structures and strategies to interfere with the host anti-viral defense. 
Materials and Methods
87
CHO-K1 cells and RNA virus infections
88
The susceptibility of CHO-K1 cells to viral infection has been previously reported 3 . Since infectivity 89 was demonstrated for viruses of a variety of families (harboring distinct genomic structures), we selected 90 the following RNA viruses from three different families to be used as prototypes: Vesicular stomatitis 91
virus (VSV, ATCC® VR-1238), Encephalomyocarditis virus (EMCV, ATCC® VR-129B), and 92
Reovirus-3 virus (Reo-3, ATCC® VR-824). Viral stocks were generated in susceptible Vero cells as per 93 standard practices using DMEM (Dulbecco's Modified Eagle's medium) supplemented with 10% FBS, 94 2mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin (DMEM-10). Viral stocks were 95 titered by tissue culture infectious dose 50 (TCID 50 ) on CHO-K1 cells and used to calculate the 96 multiplicity of infection in the experiments (Table 1) . 97
Virus infection procedures. Cells were seeded in cell culture plates (3x10 5 and 1.2x10 6 cells/well 98 in 96-well and 6-well plates, respectively) and grown overnight in RPMI-1040 supplemented with 10% 99 FBS, 2mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin, 10 mM Hepes, 1x non-100 essential amino acids and 1 mM sodium pyruvate (RPMI-10 by SDS-PAGE using 10-20% Tris-Glycine gels (Thermo Fisher Scientific) under reducing conditions. 123
As a molecular weight marker, protein ladder (cat# 7727S) from Cell Signaling Benjamini-Hochberg FDR correction, genes with adjusted p-values less than 0.05 and fold change 161 greater than 1.5 were considered as differentially expressed genes (DEGs). Table S1 Reo-3, but not VSV and EMCV ( Figure 1C) . Nevertheless, the virus-induced IFN mRNA response in 196 the host cell was insufficient to prevent cell culture destruction. These data suggest a possible inhibition 197 of the antiviral type I IFN response that varies across viruses, as previously reported 38-41 . 198 To explore why the induced type I IFN failed to mount a productive antiviral response in CHO 199 cells, we conducted RNA-Seq and pathway analysis using GSEA (see details in Text S3 and Table S1 Figures 3A-C, right panels) . At 78h, the extent of cell culture damage by Reo-3, however, 262 was milder than by VSV and EMCV at a shorter incubation times (30h and 54h, respectively) (Panels 263
Vm in Figures 3A-C) , possibly since Reo-3 induced higher levels of anti-viral related genes in the CHO 264 cells but VSV and EMCV did not ( Figures 1C, 1D and 1E) . Notably, although poly I:C pre-treatment 265 conferred protection of CHO cells to all three viral infections (Panels Vp in the Figure 3A-C) , striking 266 transcriptomic differences were observed (Table S4) when we compared Vm vs. Vp ( Figure S5C) . Nevertheless, the outcome of infection was surprisingly 277 different in Vm or Vp samples. To understand these differences, we searched for genes that were 278 differently modulated by poly I:C treatment in the context of Reo-3 infection. Indeed, we identified 30 279 genes ( Figure S6 and Table S6) endocytosis, p-value=2.5x10
-2 ). We also observed many of these genes significantly enriched molecular 284 functions: 1) RNA polymerase II transcription factor activity (11 genes; GO:0000981 FDR-adjusted p-285 value < 1.30x10 -15 ) and 2) nucleic acid binding transcription factor activity (12 genes GO:0001071 FDR-286 adjusted p-value < 3.54x10 -15 ) by gene set enrichment analysis (see Text S3 and Table S7 ). This suggests 287 that poly I:C treatment, 16 hours prior to virus infection, pre-disposes the cell to adopt an antiviral state 288 and might restore the host transcription machinery subverted by Reo-3 virus resulting in the protection 289 of the CHO cells. 290
Our results revealed other processes that are differentially activated or repressed between Vm 291 and Vp ( Figure 3D and Table S4 In order to better understand the role of upstream regulators in the CHO cell viral protection, we 314 examined the expression of the affected downstream target genes. Table 2 shows the regulatory pathways 315 modulated by poly I:C treatment in uninfected (m vs. p; Table 2A ) or infected (Vm vs. Vp; Table 2B ) 316 cells, and the described downstream effect. In cells surviving VSV and EMCV infection (Vp), we 317 identified regulatory networks involved in restricting viral replication (Table 2B and Figures 4A and  318 4B). These networks are predominantly regulated by the 6 transcription factors (NFATC2, STAT1, 319 IRF3, IRF5, IRF7, and TRIM24) that were also identified as transcription factors induced in poly I:C 320 treated uninfected cells (p) (Table 2A ). These findings suggest that the induction of the STAT1-321 dependent regulatory network by poly I:C treatment allows the cell to adopt an activated state that makes 322 it refractory to virus infection. In contrast, the STAT1-dependent regulatory network was not apparent 323 when comparing Reo-3 infected cells untreated and treated with poly I:C (Vm vs. Vp), because both 324
Reo-3 and poly I:C induce STAT1 in CHO cells ( Figure 1E and 2E (Table S8 ). Therefore, we selected the two negative 336 regulators, Gfi1 68 and Trim24 69 of STAT1 as knockout targets for genetic engineering in CHO-S cells 337 and subsequently tested the virus susceptibility of such KO cells, using Reo-3 and EMCV. We found 338 that the Trim24 and Gfi1 single knockout clones showed resistance to Reo-3 but moderate or no 339 resistance against EMCV ( Figure 6A 
